Depression Medicines | FDA - U.S. Food and Drug Administration
Use the following information to help you talk to your healthcare provider about medicines called antidepressants that can help treat depression. The medicine charts list FDA-approved products...
Depression | FDA - U.S. Food and Drug Administration
Jul 10, 2024 · Depression is one of the most common mental disorders in the United States. Depression does not discriminate, and can affect anyone regardless of age, race, ethnicity, or gender. What is...
FDA clears first digital treatment for depression, but experts ... - CNN
Apr 2, 2024 · The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.
Women and Depression - FDA
Aug 10, 2023 · FDA information on signs of depression, treatment and depression and pregnancy.
Spravato Nasal Spray Can Now Be Used Alone for Treatment …
2 days ago · The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression. Spravato was first approved for use in 2019 to treat people with major depressive disorder who did not respond to ...
FDA approves standalone use of J&J’s ketamine-derived depression ...
Jan 22, 2025 · The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the ...
The FDA has approved the first app to help treat depression
Apr 4, 2024 · The Food and Drug Administration has approved the first digital tool to help treat major depression. It's an app called Rejoyn, and it's only available through a prescription.
FDA approves first prescription digital therapy for major depression
Apr 5, 2024 · The U.S. Food and Drug Administration (FDA) has cleared the first prescription digital therapeutic authorized for the adjunctive treatment of major depressive disorder (MDD) symptoms.
What to Know About the New Nasal Spray for Tough Depression
3 days ago · Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...
FDA approves first-of-its-kind nasal spray for severe depression
Jan 22, 2025 · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and ...